BR0112339A - Polinucleotìdeo que codifica um polipeptìdeo, vetor de expressão recombinante, polipeptìdeo, composição farmacêutica, uso do polipeptìdeo célula, uso de um dna ou de um vetor de expressão, ou de uma célula ou de um polipeptìdeo, método para identificar peptìdeos tolerogênicos, método para a formulação de um composição farmacêutica, uso de um peptìdeo, composição de diagnóstico, e, método de diagnóstico e conjunto de teste para a detecção de células t autorreativas ativadas - Google Patents
Polinucleotìdeo que codifica um polipeptìdeo, vetor de expressão recombinante, polipeptìdeo, composição farmacêutica, uso do polipeptìdeo célula, uso de um dna ou de um vetor de expressão, ou de uma célula ou de um polipeptìdeo, método para identificar peptìdeos tolerogênicos, método para a formulação de um composição farmacêutica, uso de um peptìdeo, composição de diagnóstico, e, método de diagnóstico e conjunto de teste para a detecção de células t autorreativas ativadasInfo
- Publication number
- BR0112339A BR0112339A BR0112339-4A BR0112339A BR0112339A BR 0112339 A BR0112339 A BR 0112339A BR 0112339 A BR0112339 A BR 0112339A BR 0112339 A BR0112339 A BR 0112339A
- Authority
- BR
- Brazil
- Prior art keywords
- polypeptide
- expression vector
- pharmaceutical composition
- cell
- diagnostic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rehabilitation Therapy (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
"POLINUCLEOTìDEO QUE CODIFICA UM POLIPEPTìDEO, VETOR DE EXPRESSãO RECOMBINANTE, POLIPEPTìDEO, COMPOSIçãO FARMACêUTICA, USO DO POLIPEPTìDEO CéLULA, USO DE UM DNA OU DE UM VETOR DE EXPRESSãO, OU DE UMA CéLULA OU DE UM POLIPEPTìDEO, MéTODO PARA IDENTIFICAR PEPTìDEOS TOLEROGêNICOS, MéTODO PARA A FORMULAçãO DE UM COMPOSIçãO FARMACêUTICA, USO DE UM PEPTìDEO, COMPOSIçãO DE DIAGNóSTICO, E, MéTODO DE DIAGNóSTICO E CONJUNTO DE TESTE PARA A DETECçãO DE CéLULAS T AUTORREATIVAS ATIVADAS". A invenção descreve uma nova proteína e suas variantes assim como os genes que codificam estas proteínas. A proteína é útil na prevenção de doenças inflamatórias, mais especificamente na indução de tolerância da célula T à proteína em pacientes que sofrem de artrite reumatóide.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00202495 | 2000-07-13 | ||
| PCT/EP2001/007888 WO2002006478A2 (en) | 2000-07-13 | 2001-07-09 | Extracellular matrix protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0112339A true BR0112339A (pt) | 2003-04-15 |
Family
ID=8171796
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0112339-4A BR0112339A (pt) | 2000-07-13 | 2001-07-09 | Polinucleotìdeo que codifica um polipeptìdeo, vetor de expressão recombinante, polipeptìdeo, composição farmacêutica, uso do polipeptìdeo célula, uso de um dna ou de um vetor de expressão, ou de uma célula ou de um polipeptìdeo, método para identificar peptìdeos tolerogênicos, método para a formulação de um composição farmacêutica, uso de um peptìdeo, composição de diagnóstico, e, método de diagnóstico e conjunto de teste para a detecção de células t autorreativas ativadas |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20040072286A1 (pt) |
| EP (1) | EP1303610A2 (pt) |
| JP (1) | JP2004504030A (pt) |
| CN (1) | CN1441843A (pt) |
| AR (1) | AR033829A1 (pt) |
| AU (1) | AU2001285816A1 (pt) |
| BR (1) | BR0112339A (pt) |
| CA (1) | CA2415202A1 (pt) |
| HK (1) | HK1052533A1 (pt) |
| IL (1) | IL153649A0 (pt) |
| MX (1) | MXPA03000385A (pt) |
| WO (1) | WO2002006478A2 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102552910B (zh) * | 2010-12-31 | 2014-06-04 | 中国科学院上海生命科学研究院 | 细胞外基质蛋白1及其调节剂在制备过敏性疾病诊断或治疗药物中的应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020119452A1 (en) * | 2000-01-18 | 2002-08-29 | Phippard Deborah J. | Osteoarthritis tissue derived nucleic acids, polypeptides, vectors, and cells |
-
2001
- 2001-07-09 IL IL15364901A patent/IL153649A0/xx unknown
- 2001-07-09 EP EP01965095A patent/EP1303610A2/en not_active Withdrawn
- 2001-07-09 BR BR0112339-4A patent/BR0112339A/pt not_active Application Discontinuation
- 2001-07-09 MX MXPA03000385A patent/MXPA03000385A/es unknown
- 2001-07-09 CA CA002415202A patent/CA2415202A1/en not_active Abandoned
- 2001-07-09 AU AU2001285816A patent/AU2001285816A1/en not_active Abandoned
- 2001-07-09 US US10/332,929 patent/US20040072286A1/en not_active Abandoned
- 2001-07-09 WO PCT/EP2001/007888 patent/WO2002006478A2/en not_active Application Discontinuation
- 2001-07-09 JP JP2002512371A patent/JP2004504030A/ja not_active Withdrawn
- 2001-07-09 CN CN01812623A patent/CN1441843A/zh active Pending
- 2001-07-12 AR ARP010103305A patent/AR033829A1/es not_active Application Discontinuation
-
2003
- 2003-07-08 HK HK03104858.0A patent/HK1052533A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002006478A3 (en) | 2002-04-18 |
| CA2415202A1 (en) | 2002-01-24 |
| US20040072286A1 (en) | 2004-04-15 |
| WO2002006478A2 (en) | 2002-01-24 |
| HK1052533A1 (zh) | 2003-09-19 |
| WO2002006478A8 (en) | 2003-03-06 |
| CN1441843A (zh) | 2003-09-10 |
| MXPA03000385A (es) | 2003-09-22 |
| AU2001285816A1 (en) | 2002-01-30 |
| EP1303610A2 (en) | 2003-04-23 |
| AR033829A1 (es) | 2004-01-07 |
| JP2004504030A (ja) | 2004-02-12 |
| IL153649A0 (en) | 2003-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Holz et al. | Myelin-associated oligodendrocytic basic protein: identification of an encephalitogenic epitope and association with multiple sclerosis | |
| AU760864B2 (en) | Novel peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases | |
| EP3577462B1 (en) | Interaction between c-peptides and elastin receptor, a model for understanding vascular disease | |
| Ohman et al. | Cytosolic RNA recognition pathway activates 14-3-3 protein mediated signaling and caspase-dependent disruption of cytokeratin network in human keratinocytes | |
| BR122013006960A2 (pt) | Peptídeo sintético que é imunologicamente reativo com um anticorpo de proteína anti-citrulinado, seu uso e seu método de identificação, bem como kit compreendendo o referido peptídeo | |
| JP4794102B2 (ja) | フィブリンのシトルリン誘導体及び慢性関節リウマチの診断又は治療のためのその使用 | |
| Steiner et al. | Autoantibodies to the A/B proteins of the heterogeneous nuclear ribonucleoprotein complex: novel tools for the diagnosis of rheumatic diseases | |
| Wahren et al. | Identification of antigenic regions of the human Ro 60 kDa protein using recombinant antigen and synthetic peptides | |
| US12066436B2 (en) | Compositions and methods for diagnosing Lyme disease and for predicting Lyme disease spirochete elimination after treatment | |
| Kondo et al. | Two distinct HLA-A* 0101-specific submotifs illustrate alternative peptide binding modes | |
| WO2008132264A1 (es) | Polipéptido quimérico fibrina-filagrina citrulinado capaz de detectar los anticuerpos generados en la artritis reumatoide | |
| NZ332427A (en) | Peptides suitable for use in antigen specific immunosuppressive therapy | |
| Nishikai et al. | Anti-Jo-1 antibodies in polymyositis or dermatomyositis: evaluation by ELISA using recombinant fusion protein Jo-1 as antigen. | |
| Hoch et al. | Structures of thymosin proteins | |
| BR9908886A (pt) | Gene codificando um marcador para câncer | |
| BR0112339A (pt) | Polinucleotìdeo que codifica um polipeptìdeo, vetor de expressão recombinante, polipeptìdeo, composição farmacêutica, uso do polipeptìdeo célula, uso de um dna ou de um vetor de expressão, ou de uma célula ou de um polipeptìdeo, método para identificar peptìdeos tolerogênicos, método para a formulação de um composição farmacêutica, uso de um peptìdeo, composição de diagnóstico, e, método de diagnóstico e conjunto de teste para a detecção de células t autorreativas ativadas | |
| Drouin et al. | Molecular characterization of the OspA161–175 T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato | |
| Kotani et al. | Identification of thyroiditogenic epitope on porcine thyroid peroxidase for C57BL/6 mice. | |
| Bichsel et al. | Requirements for the quality control of chemically synthesized peptides and biotechnologically produced proteins | |
| Imamura et al. | A novel nonmuscle alpha-actinin. Purification and characterization of chicken lung alpha-actinin. | |
| AU2009235953B2 (en) | Modified Cpn10 and PRR signalling | |
| BR9608626A (pt) | Peptédeo preparação farmacéutica e uso de um peptídeo | |
| BR0308095A (pt) | Teste para anticorpos anti-ingap | |
| Kajihara-Kano et al. | Characterization of S-hexylglutathione-binding proteins of human hepatocellular carcinoma: separation of enoyl-CoA isomerase from an Alpha class glutathione transferase form | |
| TW581812B (en) | Assay for the diagnosis of schizophrenia based on a new peptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |